Delivery Order SPE2DR25D3303-SPE2DR26F67A5
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets (90-count packages) with a contract ceiling value of $11,562.78. This is a firm fixed-price delivery order with an ultimate completion date of January 6, 2026, utilizing no set-aside designation and awarded through competitive procurement. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 26, 2026, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $117,091.18. This is a firm fixed-price delivery order with no set-aside designation, executed under competitive procurement procedures. The contract is scheduled for ultimate completion by January 27, 2026, with performance at the contractor's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 5, 2026, for the supply of Jardiance 10 mg tablets in a quantity of 90 units, with a ceiling value of $2,406.07. This is a firm fixed price delivery order with an ultimate completion date of January 6, 2026, issued under a non-competitive set-aside arrangement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,931.26 to AmerisourceBergen Drug Corp for the supply of Jardiance 10 mg tablets (90-count units) on January 16, 2026, with an ultimate completion date of January 20, 2026. This firm fixed-price delivery order was not set aside and represents a competitively awarded contract supporting federal medical procurement needs. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 27, 2026, for the supply of Jardiance 10 mg tablets (90-count units) valued at $1,579.10, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the awardee's location in Conshohocken, Pennsylvania. The contract represents a task order under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 6, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $3,462.82. This is a firm fixed price delivery order with an ultimate completion date of June 9, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,313.76 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was awarded competitively and represents a single transaction under AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The...
- The Defense Logistics Agency awarded a delivery order valued at $8,921.73 to AmerisourceBergen Drug Corp for the supply of Jardiance 25 mg tablets (90-count units) on January 7, 2026, with completion expected by January 8, 2026. This firm fixed-price delivery order was competitively awarded without a set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. (doing business as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a ceiling value of $16,237.23 under a firm fixed-price contract. This non-competitive delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor, AmerisourceBergen was selected to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count) with a contract ceiling value of $31,642.05. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 15, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal...
- SPE2DR25D3303Indefinite Delivery Contract
- SPE2DR25D3303-SPE2DR26F67A5Delivery Order
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on January 29, 2026, for the supply of Jardiance 25 mg tablets (90-count units) with a contract ceiling value of $7,763.89. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of January 30, 2026. AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., serves as the prime contractor and is a major pharmaceutical distributor specializing in supplying medications and medical supplies to federal healthcare systems. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables the company to deliver a wide range of brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. Jardiance, an oral diabetes medication, represents one of the many pharmaceutical products delivered through this expansive contract vehicle to support federal military and veteran healthcare needs.